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Abstract.  We examined the role of innervation on 
acetylcholinesterase (ACHE) gene expression within 
mammalian  skeletal muscle fibers. First,  we showed 
the selective accumulation of AChE mRNAs within 
the junctional vs extrajunctional  sarcoplasm of adult 
muscle fibers using a quantitative reverse transcription 
PCR assay and demonstrated by in situ hybridization 
experiments that AChE transcripts  are concentrated 
immediately beneath the postsynaptic membrane of the 
neuromuscular junction.  Next, we determined the 
influence of nerve-evoked activity vs putative trophic 
factors on the synaptic accumulation of AChE mRNA 
levels in muscle fibers paralyzed by either surgical 
denervation or selective blockage of nerve action 
potentials with chronic  superfusion of tetrodotoxin. 
Our results indicated that muscle paralysis leads to a 
marked decrease in AChE transcripts  from the post- 
synaptic sarcoplasm,  yet the extent of this decrease is 
less pronounced after tetrodotoxin inactivation than af- 
ter denervation.  These results suggest that although 
nerve-evoked activity per se appears a key regulator of 
AChE mRNA levels, the integrity of the synaptic 
structure or the release of putative trophic factors con- 
tribute to maintaining  the synaptic accumulation of 
AChE transcripts at adult neuromuscular synapses. 
Furthermore,  the pronounced downregulation of AChE 
transcripts  in paralyzed muscles stands in sharp con- 
trast to the well-documented increase in nicotinic ace- 
tylcholine receptor mRNAs under these conditions, 
and indicates that expression of the genes encoding 
these two synaptic proteins are subjected to different 
regulatory mechanisms in adult muscle fibers in vivo. 
XPRESSION of several components of the adult neuro- 
muscular synapse is strongly influenced by the pres- 
ence of the motor nerve,  as well as by muscle con- 
tractile activity. One dramatic example of such highly refined 
regulation  is  that  of the  nicotinic  acetylcholine  receptor 
(AChR). t  In  intact  muscle  fibers,  AChR  selectively  ac- 
cumulates at the postsynaptic  membrane, where it reaches 
a density of 10,000-20,000  molecules/#m  2.  Upon surgical 
denervation,  AChRs appear in extrajunctional  regions as a 
result of de novo synthesis (for review see Fambrough, 1979; 
Salpeter,  1987; Hall and Sanes,  1993). These changes in the 
spatial distribution  of AChR along muscle fibers are accom- 
panied by profound modulations in the expression  of genes 
encoding the various AChR subunits  in junctional and ex- 
trajunctional  regions of skeletal muscle fibers, modulations 
governed by both nerve-evoked  muscle activity and neuro- 
chemical factors (Merlie et al.,  1984; Fontaine  and Chan- 
geux, 1989; Goldman and Staple,  1989; Witzemann  et al., 
1991). 
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Acetylcholinesterase  (ACHE) is another major constituent 
of the neuromuscular synapse responsible for the rapid hy- 
drolysis  of acetylcholine  released  from  nerve  terminals 
(Massouli6 and Bon, 1982; Brimijoin,  1983; Rotundo, 1987; 
Taylor, 1991; Massouli6 et al., 1993). This enzyme is of par- 
ticular interest  with regard to muscle plasticity  since levels 
of AChE molecular forms are known to be highly sensitive 
to neural influences. For example, muscle paralysis induced 
via surgical denervation  generally results in the rapid disap- 
pearance of the synaptic  collagen-like  tailed AChE  forms 
(Hall,  1973;  Vigny et al.,  1976;  Fernandez  et al.,  1979; 
Bacou et al., 1982; Collins and Younkin, 1982; Lomo et al., 
1985). In addition,  blockade of action potential propagation 
with tetrodotoxin (Butler et al., 1978; Cangiano et al., 1980) 
or of neuromuscular transmission  with botulinum toxin A 
(Stromblad,  1960;  Drachman,  1972)  lead to pronounced 
decreases in total AChE activity that include reductions  in 
the  amount  of the  asymmetric  form  A12  (Sketelj  et al., 
1993).  Alternatively,  enhanced  neuromuscular  activation 
causes significant increases  in whole muscle AChE activity 
that  are  reflected  by  specific  and  prominent  changes  in 
the levels of the various  molecular forms (Fernandez  and 
Donoso,  1988;  Jasmin and Gisiger,  1990;  Gisiger et al., 
1991; Jasmin et al., 1991). Taken together, these studies indi- 
cate that  regulation  of AChE  expression  in  adult skeletal 
muscle is a multifactorial  process that may involve, in addi- 
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substances, as well as passive and active mechanical factors. 
In contrast to the recent advances regarding our under- 
standing of the mechanisms involved in AChR expression, 
knowledge concerning the cellular and molecular basis un- 
derlying the neural regulation of AChE molecular forms in 
muscle is still rudimentary. Within the last few years, how- 
ever, several laboratories have succeeded in isolating eDNA 
and genomic clones encoding AChE in a variety of species 
(Schumacher et al.,  1986; Sikorav et al., 1987; Rotundo et 
al.,  1988;  Maulet et al.,  1990;  Rachinsky et al.,  1990;  Li 
et al., 1991; Legay et al., 1993a), thus allowing for the study 
of the cellular and molecular mechanisms involved in the 
regulation and localization of AChE in muscle fibers. We 
have recently initiated a series of experiments to specifically 
address this issue in vivo (Jasmin et al.,  1993).  At first, 
we concentrated on the molecular basis underlying the accu- 
mulation of AChE at the avian neuromuscular junction by 
comparing levels of AChE transcripts in junctional vs extra- 
junctional regions of skeletal muscle fibers. Using a quanti- 
tative reverse transcription PCR (RT-PCR)-based assay, we 
showed the accumulation of AChE mRNAs within the junc- 
tional sacroplasm. The next step is to investigate the neural 
factors regulating the selective accumulation of AChE tran- 
scripts within the postsynaptic sarcoplasm of the neuromus- 
cular junction. 
In the present studies, we have examined this by using two 
well-characterized models of muscle paralysis, surgical de- 
nervation and chronic superfusion of tetrodotoxin (TTX). 
With denervation the nerve is severed from its target muscle 
cells, whereas chronic TTX delivery onto the nerve blocks 
the propagation of action potentials while preserving the in- 
tegrity of nerve-muscle  contacts and maintaining axonal 
transport (Lavoie et al., 1976).  Our results indicate that al- 
though nerve-evoked muscle electrical activity per se ap- 
pears a key regulator of AChE mRNA levels,  the integrity 
of the synaptic structure or the release of putative trophic 
factors contribute to maintaining the synaptic accumulation 
of AChE transcripts at adult neuromuscular synapses. 
Materials and Methods 
Surgery and Muscle Sample Preparation 
Female Sprague Dawley rats weighing between 180 and 200 g were ran- 
domly assigned to one of three experimental groups: (a) control; (b) dener- 
vated (DEN); and (c) TTX-inactivated (TTX). All animal surgery was per: 
formed under aseptic conditions with the animals anesthetized with sodium 
pentobarbital (35 mg/kg i.p.). The left soleus, plantaris, and EDL muscles 
of control rats were quickly excised and frozen in liquid nitrogen. Left hind- 
limb muscles of DEN animals were denervated by cutting and removing a 
4-mm segment of the sciatic nerve 10 mm distal to the sciatic notch. The 
incision was closed with suture clips, and the animal was returned to its 
cage. TTX rats were implanted with a chronic drug delivery system as de- 
scribed in detail  elsewhere (Michel  and Gardiner,  1990;  Michel et al., 
1994).  Briefly,  a  mini-osmotic pump (Alza Corp.,  Palo Alto, CA) and a 
silastic tubing and cuff system were loaded with ,0250/~1 of sterile physio- 
logical saline containing 350 ttg/ml TTX (Sigma Immunochemicals, St. 
Louis, MO). The cuff was carefully positioned around the sciatic nerve dis- 
tal to the sciatic notch, and was sealed with 3.0 surgical silk. During this 
procedure, care was taken to avoid any damage to the nerve. The fitting of 
the cuff was such that it allowed for its sliding along the longitudinal axis 
of the sciatic nerve. The silastic cuff and connecting tube were secured in 
place by suturing the overlying hamstring musculature with silk. The tubing 
and pump attachment were led subcutaneously to the L2 region on the 
animal's back. 10 d after denervation or TTX-induced paralysis, left soleus, 
plantaris, and EDL muscles were excised and frozen as for control muscles. 
Efficacy of TTX-induced Paralysis 
Animals were checked twice daily to ensure the completeness of left hind- 
limb paralysis using as indicators of recovery: (a) toe spreading in response 
to hindlimb unweighting; (b) the flexor reflex in response to pinching of the 
foot pad; and (c) plantar flexion in response to forced dorsi-ffexion of the 
ankle. None of the animals included in this study demonstrated any of these 
responses at any time. In a parallel study (Jasmin et al., 1994b), the efficacy 
of the TTX block was verified before removal of the hindlimb muscles by 
stimulating  the sciatic nerve proximal to the silastic cuffwith a bipolar plati- 
num electrode at supra-maximal voltages and monitoring the functional re- 
sponse of the exposed triceps surae musculature. This procedure never 
elicited a contractile response from TTX-inactivated muscles. At the time 
of muscle excision, the silastic cuff was removed, and the integrity of the 
sciatic nerve was assessed. Signs of swelling and connective tissue prolifera- 
tion were never observed. Finally, muscle weight loss caused by TTX inacti- 
vation was identical to that induced by cutting the sciatic nerve in all mus- 
cles studied indicating that the entire muscle fibre population had been 
successfully inactivated. 
In separate experiments, the possibility that partial or total denervation 
may have occurred as a result of the silastic cuff was also examined. This 
was done using both histological and functional criteria. First, by combin- 
ing acetylcholinesterase histochemical stain with silver staining of nerve 
terminals (Alderson et al.,  1989),  we observed that the number of post- 
synaptic membranes contacted by a single mature myelinated nerve termi- 
nal in TTX-inactivated muscles was identical to unoperated control muscles 
(Boudreau,  C.,  and R.  N.  Michel, manuscript in preparation).  Second, 
comparison of muscle maximal force production between stimulation of the 
sciatic nerve distal to the silastic cuff with direct stimulation of the muscle 
never differed by >5%  (see also Michel and Gardiner,  1990; and Michel 
et al.,  1994). 
Microdissection of Small Bundles 
of  EDL Muscle Fibers 
In another series of experiments, microdissected muscle samples consisting 
of junctional and extrajunctional regions were examined (see Jasnlin et al., 
1993). For these studies, the EDL muscle was excised and pinned at resting 
length on a  paraffin bed.  To visualize neuromuscular junctions, muscles 
were then injected with and immersed in an AChE histochemical buffer so- 
lution (Karnovsky and Roots, 1964). After 1 h of staining, small bundles 
containing 10-15 muscle fibers were microdissected under a stereomicro- 
scope.  This involved separating, but not detaching, the bundle from the 
muscle by gently teasing off the connective tissue. The region containing 
the neuromuscular junctions was then cut from the bundle along with an 
adjacent extrajunctional segment of similar size. Total RNA from each sam- 
ple was then immediately extracted (see below). Time for dissection was 
limited to 1 h to minimize possible RNA degradation. We determined that 
RNA degradation was negligible under these time and dissection conditions 
(see also Jasmin et al., 1993). In our experiments, this was done by compar- 
ing levels of AChE and dystrophin transcripts in EDL muscles homogenized 
immediately after excision to those observed in EDL muscles incubated for 
2 h in the Karnovsky and Roots buffer-substrate solution. Under these con- 
ditions, there was no detectable decline in the mRNA levels of AChE and 
dystrophin. 
Extraction of  RNA and Quantitative RT-PCR 
Total RNA from whole muscles was extracted using the acid guanidinium 
phenol chloroform procedure previously described by Chomczynski and 
Sacchi (1987). Whole muscles were placed in an appropriate volume (10 
#l/ftg tissue) of denaturing solution D and homogenized using a  Polytron 
(Kinematica, Littan,  Switzerland)  set at maximum speed for 2  x  15 s. 
Microdissected tissue samples were consistently homogenized in 500 #1 of 
denaturing solution D. Total RNA was stored at -20"C in 75 % ethanol until 
further analysis. 
For whole muscle experiments, RNA pellets were dissolved in an appro- 
priate volume of RNase-free water according to the mass of control mus- 
cles. From each stock RNA sample, 10 #1 was then diluted 10-, 100-, 1,000- 
and 10,000-fold, and only 2 fd of diluted RNA was reverse transcribed (,°2 
/zg for 10-fold dilution). The reverse transcription mixture contained 5 mM 
MgCI2, Ix PCR buffer II (50 mM KC1, 10 mM Tris-HC1 [pH 8.3]),  1 mM 
dNTPs, 20 U RNase inhibitor, 50 U Moloney murine leukemia virus re- 
verse transcriptase, and 2.5 mM random hexamer primers (GeneAmp RNA 
PCR kit; Perkin-Elmer Cetus Instruments, Norwalk, CT).  For microdis- 
sected junctional and extrajunctional muscle samples, RNA pellets were 
directly dissolved in 20 #1 of reverse transcription mixture (see Jasmin et 
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which RNA was replaced by RNase-free water. Reverse transcription was 
performed for 45 min at 42°C, and the reaction was terminated by heating 
to 99°C for 5 min. 
To amplify AChE cDNAs, specific synthetic primers based on the rat 
AChE cDNA sequence were used (Legay et al.,  1993b).  These 5' (CTG- 
GGGIV_rCGGATCGGT)  and 3' (TCACAGGTCTGAGCAGCGTT)  primers 
were located in exons 2 and 6 of the AChE consensus gene map, respec- 
tively. These primers amplified a 670-bp target sequence encoding part of 
the asymmetric collagen-tailed form of ACHE. For some of these experi- 
ments, dystrophin cDNAs were also amplified using primers based on the 
mouse sequence (Tanaka  and Ozawa,  1990;  Ho-Kim and Rogers, 1992). 
The  expected  PCR  product  using  5'  (TGAAATAATGGAGGAGAGA- 
CTCGG) and 3' (GCAGGCCATTCCTCTTTCAGGAAA) primers for dys- 
trophin was 3t4 bp. PCR was performed by adding 5 #l of reverse transcrip- 
tion mixture to 20 #l of a  solution containing 0.625  U  AmpliTaq DNA 
polymerase, 0.25 #g each of the appropriate 5' and 3' primers, and MgCl2 
and PCR buffer II (final concentrations of 2 mM and  lx, respectively). 
Each PCR reaction mixture was overlaid with mineral oil before the tubes 
were placed in a DNA thermal cycler (Perkin-Elmer Corp.). For both AChE 
and dystrophin, each cycle consisted of denaturation at 94°C for 1 rain, and 
primer annealing and extension at 70°C for 3 rain. A final  10-rain elonga- 
tion step at 72°C was added after the last cycle.  PCR products were kept 
at 4°C until gel electrophoresis. Typically,  34 and 42 cycles of amplification 
were performed for whole muscle and  microdissected samples, respec- 
tively, since preliminary data showed that these cycle numbers were within 
the linear range of amplification. Ten #1 of the PCR products were visual- 
ized on either a  1 or 1.5%  agarose gel containing ethidium bromide. The 
100-bp ladder (Gibco BRL,  Gaithersburg, MD) DNA molecular weight 
marker was used to estimate the size of  the PCR products. Quantitative PCR 
experiments under noncompetitive conditions were performed since, in the 
present studies, we were primarily  interested in comparing the relative 
abundance of AChE mRNAs in different muscles subjected to various ex- 
perimental conditions. These experiments were performed as described in 
detail in Jasmin et al. (1993).  Counts per minute obtained for AChE PCR 
products from junctional and extrajunctional regions were adjusted accord- 
ing to the levels of dystrophin present in the same RT samples. Thus, for 
comparison of the relative abundance of AChE transcripts in junctional vs 
extrajunctional regions of EDL muscle fibers, we took into consideration 
that the size of microdissected  fiber segments may vary from sample to sam- 
ple, and we standardized our AChE PCR results accordingly. We previously 
used this procedure to account for the size differences between fiber seg- 
ments (Jasmin et al.,  1993). 
In Situ Hybridization Experiments 
For these studies, EDL and soleus muscles were quickly excised, mounted 
onto cardboard backing with Tissue Tek (Miles Inc., Elkhart, IN) mounting 
medium, and frozen in melting isopentane cooled with liquid nitrogen. 
Serial sections (12 t~m) were obtained on a cryostat, placed on alternate Su- 
perfrost plus slides (Fisher Scientific Co., Pittsburgh, PA),  and stored at 
-80°C until further analyses. Alternate slides were either stained with the 
AChE histochemical staining (Karnovsky and Roots, 1964) to allow visual- 
ization of neuromuscular junctions or were subjected to in situ hybridization 
using a synthetic oligonucleotide for detection of AChE transcripts. In some 
experiments, sections were first stained with the histochemical staining pro- 
cedure and the regions containing neuromuscular junctions were photo- 
graphed. The sections were subsequently processed for in situ hybridization 
using an 35S-labeled  synthetic oligonucleotide probe (5', 3';CAAGTCA- 
ATGTGGAGGCACGGTGTTCAAAGATGTAGGCATAGACCCG- 
AGC) complementary to rat AChE transcripts (Legay et al., 1993a), as de- 
scribed by Schalling et al.  (1988). 
Extraction and Analysis of  AChE Enzyme Activity 
For these experiments, soleus, plantaris, and EDL muscles from control, 
denervated, and TTX-inactivated rats were excised and frozen in liquid 
nitrogen. They were subsequently homogenized on ice in 2.5 ml of a high 
salt  detergent  buffer  containing  as  antiproteolytic  agents  bacitracin  (1 
mg/ml) and aprotinin (25 U/ml). Homogenization was performed for 2  × 
15  s with a  Polytron (Kinematica) set at 6.  The homogenates were cen- 
trifuged (20,000 g) at 4°C for 15 rain. Aliquots of the supernatants were 
kept at  -80°C until further analysis. 
AChE activity was measured using the spectrophotometric method of 
Ellman et al. (1961) in the presence of 10  -5 M of the nonspecific cholines- 
terase  inhibitor  tetraisopropylpyrophosphoramide (iso-OMPA),  as  de- 
scribed previously (Gisiger and Stephens, 1988; Jasmin and Gisiger, 1990). 
Nonspecific hydrolysis was determined by measuring substrate hydrolysis 
in the presence of both iso-OMPA and the AChE-specific inhibitor 5-bis(4- 
allyldimethylanunonium phenyl)pentanone dibromide (BW284c51). 
Results 
Accumulation of  AChE mRNA at Mammalian 
Neuromuscular Synapses 
Initially, we  determined  whether  AChE  transcripts  were 
more abundant in junctional regions of rat skeletal muscle 
fibers as compared to extrajunctional regions by measuring 
both AChE and dystrophin mRNA levels in pairs of segments 
isolated from the same muscle fibers using quantitative RT- 
PCR (see Jasmin et al.,  1993).  For amplification of ACHE, 
primers that amplified a 670-bp fragment specifically corre- 
sponding to the rat AChE T subunit were used (Legay et al., 
1993b).  In these assays,  sample size was estimated by mea- 
suring the relative abundance of dystrophin transcripts in the 
same  samples  since  dystrophin is  a  cytoskeletal protein 
evenly distributed throughout the length of individual muscle 
fibers (Ahn and Kunkel, 1993;  Matsumura and Campbell, 
1994).  Also, our preliminary in situ hybridization experi- 
ments indicated that the distribution of  dystrophin transcripts 
is relatively homogeneous throughout the sarcoplasm. The 
relative amount of dystrophin mRNAs was also determined 
by quantitative RT-PCR using primers that selectively am- 
plify a 314-bp fragment (Tanaka and Ozawa, 1990; Ho-Kim 
and Rogers,  1992). 
For  these  experiments,  the  extensor  digitorum  longus 
(EDL) muscle was chosen because of the relative ease with 
which small bundles of fibers may be microdissected. Af- 
ter AChE histochemical staining, bundles of fibers contain- 
ing  10-15  neuromuscular junctions were carefully teased 
from the muscle, and cut into junctional and extrajunctional 
regions of similar sizes. Total RNA was then extracted from 
each sample, reverse transcribed using random hexamers, 
and the resulting AChE and dystrophin cDNAs were am- 
plified.  An  example of an  ethidium bromide-stained gel 
showing AChE and dystrophin PCR products in junctional 
vs extrajunctional regions of small bundles of microdissected 
fibers obtained from an EDL muscle is shown in Fig. 1. As 
illustrated, AChE mRNA levels were considerably higher in 
junctional regions as compared to extrajunctional regions, 
while dystrophin transcripts were relatively equal in both 
samples (n =  9 different EDL muscles representing a total 
of 53 junctional vs extrajunctional comparisons). Quantita- 
tive analysis revealed that, on average, AChE mRNA levels 
were •5-  to 14-fold higher in junctional vs extrajunctional 
regions of EDL muscle fibers (n =  6 EDL muscles), values 
that correspond closely to our earlier findings in avian mus- 
cle (Jasmin et al.,  1993). 
To complement our quantitative RT-PCR experiments and 
to ascertain that the accumulation of AChE mRNAs was lo- 
cated immediately beneath the postsynaptic membrane of rat 
neuromuscular synapses, we performed a series of in situ hy- 
bridization experiments on EDL and soleus muscles. Lon- 
gitudinal cryostat sections obtained from these two muscles 
were incubated with a synthetic 35S-labeled oligonucleotide 
(50 mer) complementary to the common coding region of 
AChE mRNAs. The localization of AChE transcripts in these 
tissue sections was compared to either its respective serial 
cryostat section histochemically stained to visualize neu- 
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and extrajunctional regions of skeletal muscle fibers. Small muscle 
fiber bundles each containing between 10-15 individual fibers were 
isolated from the EDL muscle. From each fiber bundle, junctional 
segments and their respective adjacent extrajunctional regions were 
microdissected. RT-PCR products corresponding to AChE and dys- 
trophin (DYS) mRNAs within these specific muscle compartments 
were visualiz~ on an ethidium bromide-stained agarose gel. June- 
tional and extrajunctiunal levels of AChE (lanes 1 and 2, respec- 
tively) and dystrophin (lanes 3 and 4, respectively) transcripts are 
shown. Note the greater accumulation of AChE mRNAs in junc- 
tional vs extrajunctional regions compared to dystrophin mRNAs, 
which were similar in these two compartments. 
romuscular  synapses,  or to photographs  of neuromuscular 
junctions  taken before hybridization  from the  same tissue 
section (see Materials and Methods).  Results of our experi- 
ments disclosed accumulations of silver grains correspond- 
ing  to  the  presence  of  AChE  transcripts  within  the  sar- 
coplasm immediately beneath the postsynaptic membrane of 
neuromuscular  synapses,  thus  confirming  the  results  ob- 
tained by quantitative RT-PCR (Fig.  2). Interestingly,  it ap- 
peared that the accumulation of AChE transcripts within the 
postsynaptic  sarcoplasm  of soleus  muscle  fibers  was  less 
striking than that observed in EDL fibers (compare Fig.  2, 
B  and D),  a  finding  which  may be related  to the  fact that 
soleus  muscles  appeared  to contain  less  AChE  transcripts 
than  EDL muscles (Fig.  3). 
Neural Regulation of  AChE mRNA levels in 
Rat Hindlimb Muscles 
To determine the neural factors responsible for the selective 
accumulation  of AChE  transcripts  within  the  postsynaptic 
sarcoplasm of mammalian neuromuscular  synapses,  we ex- 
amined AChE mRNA levels in hindlimb muscles paralyzed 
by either sciatic nerve section or chronic superfusion of TTX 
Figure 2. Subcellular localization of AChE mRNA 
in individual EDL (A and B) and soleus (C and D) 
muscle  fibers.  (A)  A  representative  bright-field 
photomicrograph of  a longitudinal cryostat section 
of EDL muscle fibers stained for the histochemi- 
cal demonstration of AChE to localize neuromus- 
cular junctions (Karnovsky and Roots,  1964).  (B) 
A dark-field photomicrograph of its corresponding 
serial section processed for in situ  hybridization 
using a synthetic probe complementary to AChE 
transcripts. Comparison of these two panels high- 
lights the codistribution  of neuromuscular junc- 
tions and  silver grains corresponding  to the ex- 
pression of AChE mRNAs (curved arrows point to 
some examples). This indicates that the selective 
accumulation of AChE transcripts within the junc- 
tional region of individual skeletal muscle fibers is 
confined to the area of  the sarcoplasm immediately 
beneath the postsynaptic membrane. Also, note the 
presence of a  neuromuscular junction without a 
corresponding accumulation of AChE mRNAs (,4 
and B), open arrowhead. Bar, 60/zm. (C and D) 
Representative  bright-field  and  dark-field  pho- 
tomicrographs  of a  single  longitudinal  cryostat 
section from a  soleus muscle processed first for 
AChE histochemistry and subsequently for in situ 
hybridization to localize AChE transcripts.  Note 
the colocalization of neuromuscular junctions and 
AChE  mRNAs  although  the  accumulation  of 
AChE  transcripts  appears less  striking  than  for 
EDL muscle. Bar,  120/~m. 
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Figure 3. Comparison of AChE transcript levels in EDL and SOL 
muscles.  (A) Ethidium bromide-stained agarose gels of  AChE PCR 
products after serial  dilutions  of total RNA extracted  from EDL 
and SOL muscles. Dilutions  were (from left to right on respective 
gels):  1/100, 1/10000, and 1/100000. (B) Graphic representation of 
serial  dilutions  shown in A based on the amount of 32p-labeled 
primers incorporated in the PCR product. Linearity of PCR prod- 
uct amplification  was  achieved  over two orders of magnitude of 
RNA input.  Note the higher levels of AChE transcripts at all RNA 
concentrations  observed  in  the  predominantly  fast-twitch  EDL 
muscle compared to the predominantly slow-twitch  SOL muscle. 
onto the sciatic nerve. This approach allowed us to examine 
the  roles  of nerve-induced  electrical  activity  vs  putative 
nerve-derived trophic factors in the regulation and accumu- 
lation  of AChE transcripts  within  the  postsynaptic  mem- 
brane  domain.  The  efficacy  of  the  TTX  treatment  was 
verified using several functional and morphological criteria 
(see Materials and Methods). The fact that the mass of EDL, 
plantaris, and soleus muscles that were inactivated by either 
denervation or TTX paralysis was reduced to a similar extent 
after 10 d of inactivity indicates that all fibers of TTX para- 
lyzed muscles had been completely inactivated (Fig.  4). 
Although  the  loss  in  mass  was  similar  after  paralysis, 
denervation  and  chronic  TTX  superfusion  affected  total 
AChE enzyme activity to different extents.  10 d after dener- 
vation, AChE activity was downregulated considerably in all 
three muscles studied with the effect being more pronounced 
in EDL muscles (Fig.  5).  The effect of denervation was in- 
deed severe in this latter muscle since denervated EDL mus- 
cles had only ~9 % of AChE activity remaining as compared 
to control muscles.  Chronic superfusion of TTX onto the 
sciatic  nerve also resulted  in decreases  in total  AChE en- 
zyme activity (Fig. 5). However, in contrast to what was ob- 
served with muscle mass, the loss in AChE activity was at- 
EDL  PL  SOL 
Figure 4. Histogram ofEDL, PL, and SOL muscle mass after com- 
plete paralysis.  Mass for each respective muscle were compared af- 
ter  10 d of either denervation  or TTX inactivation  of the sciatic 
nerve.  Values are means  +SD expressed  as a percent of control 
values. Note the significant but similar loss in mass for each muscle 
type compared to control muscles, regardless  of the condition of 
disuse.  I1, DEN; [], TXX. 
tenuated  after  TTX  inactivation.  For  instance,  in  EDL 
muscles inactivated for 10 d by TTX, AChE activity was re- 
duced by 75 % compared to the 90 % seen with denervation. 
The differential impact of denervation and TTX inactivation 
on AChE activity was also observed for plantaris and soleus 
muscles. 
Similar to the effects of paralysis on AChE enzyme activ- 
ity, transcript levels were markedly affected by the period of 
inactivity. Interestingly, the effects of both inactivity models 
paralleled the downregulation of enzyme levels since AChE 
transcript levels in all three muscles studied decreased to a 
greater extent after denervation than after TTX treatment. 
For instance, AChE transcripts levels in EDL muscles were 
decreased by more than 10-fold after denervation, but were 
much less reduced in TTX-paralyzed muscles (Fig. 6). This 
was also the case for plantaris and soleus muscles. The pro- 
nounced  decrease  in  AChE  transcript  levels  after  either 
denervation or TTX treatment was confirmed with a  series 
100 t  ............................... 
80 
[., 
z  6O 
~  40 
2o 
0 
EDL  PL  SOL 
Figure 5. Histogram of AChE activity in EDL, PL, and SOL mus- 
cles after complete paralysis.  AChE enzyme activity was measured 
in each of these muscles after 10 d of either denervation or TTX 
inactivation  of the sciatic nerve.  Values are means +SD expressed 
as a percent of control values.  Total AChE enzyme activity was 
markedly lower than control in all muscles as a result of paralysis. 
Note, however,  the differential  effect on this  parameter between 
both conditions of disuse.  II, DEN; [], TTX. 
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Figure 6.  Effect of denervation and  TTX-induced paralysis  on 
AChE transcript levels. (A) Ethidium bromide-stained agarose gels 
of AChE PCR products for control (CON), denervated (D), and 
TTX-treated (T) EDL muscles. The negative control lane is marked 
with a -. Serial dilutions of RNA extracts from CON muscles are 
shown (from left to fight:  1/10, 1/100, 1/1000, and 1/10000), and 
the linear phase plotted in B is based on the amount of 32p-labeled 
primers incorporated. Since AChE PCR product amplification was 
linear over two orders of  magnitude of  RNA input, the highest RNA 
concentration (1/10 dilution) was used to compare PCR products 
from D and T muscles. Note attenuated loss in AChE transcripts 
from  control  values  in  TTX-inactivated muscles  compared  to 
denervated counterparts. Similar results were obtained for SOL and 
PL muscles (not shown), 
of in  situ hybridization experiments and,  accordingly, ac- 
cumulations of  AChE transcripts within the postsynaptic sar- 
coplasm of inactivated EDL and soleus muscle fibers could 
no longer be observed after the period of inactivity. Yet, neu- 
romuscular junctions  were  still  easily  detected by AChE 
histochemical staining (Fig. 7). 
Discussion 
In the present studies, we have examined the effects of two 
well-characterized models of hindlimb muscle disuse, surgi- 
cal denervation, and chronic superfusion of TTX onto the 
sciatic nerve, on the selective accumulation of AChE tran- 
scripts within the postsynaptic sarcoplasm of rat neuromus- 
cular synapses. With denervation, action potential propaga- 
tion and axonal transport are eliminated, whereas chronic 
TTX delivery onto the nerve blocks the propagation of  action 
potentials  while preserving the integrity of nerve-muscle 
contacts and maintaining axonal transport. This approach, 
therefore,  allowed us  to  examine  the  influence of nerve- 
induced electrical activity vs putative trophic factors consti- 
tutively expressed (activity-independent) in  the regulation 
and selective accumulation of AChE transcripts within the 
postsynaptic membrane domain. 
Neural Regulation of  AChE mRNA at the Mammalian 
Neuromuscular Synapse 
Our recent studies have indicated that AChE transcripts are 
accumulated within the junctional region of avian neuromus- 
cular  synapses  (Jasmin  et al.,  1993).  Our current results 
confirm  and  extend these  findings.  Quantitative  RT-PCR 
results  obtained  from microdissected bundles  showed  an 
accumulation of AChE transcripts within the junctional re- 
gion  of mammalian  skeletal  muscle  fibers.  In  addition, 
in situ hybridization experiments revealed that this accumu- 
lation  of AChE  mRNA  was  confined to  the  area  of the 
sarcoplasm that lies immediately beneath the postsynaptic 
membrane at the level of the "fundamental" myonuclei. The 
mechanisms responsible for the preferential accumulation of 
AChE mRNAs have not yet been elucidated, but selective ex- 
pression of the AChE gene by the junctional myonuclei may 
itself explain the observed compartmentalization. This pro- 
posed mechanism fits well with a model where genes encod- 
ing postsynaptic proteins are transcribed strictly by the end- 
plate myonuclei and locally translated (Rotundo, 1990) such 
that  the  nascent  peptide  chains  are  processed  within  the 
specialized  postsynaptic  Golgi  apparatus  (Jasmin  et  al., 
1989,  1994a) and are focally transported to the postsynaptic 
membrane by way of a microtubule-based transport mecha- 
nism (Jasmin et al., 1990; Rossi and Rotundo, 1992). How- 
ever, other mechanisms may also account for the selective 
accumulation of AChE mRNA within the postsynaptic sar- 
coplasm. In particular, transcription of the AChE gene may 
occur in all nuclei throughout the muscle fiber with transport 
of the AChE mRNA to the postsynaptic membrane domain 
or, alternatively, transcription of the AChE gene may involve 
all nuclei of the muscle fiber with enhanced stabilization of 
the mRNA within the postsynaptic sarcoplasm. 
The marked decrease in AChE enzyme activity that we ob- 
served after denervation corresponds well with other pub- 
lished reports (Hall, 1973; Vigny et al.,  1976; Fernandez et 
al.,  1979; Bacou et al.,  1982; Collins and Younkin,  1982; 
Lomo et al., 1985), as does the attenuated loss in AChE en- 
zyme activity seen after blockade of action potential propa- 
gation with TTX (Butler et al., 1978; Cangiano et al., 1980). 
Interestingly, these changes in enzyme activity were paral- 
leled by similar decreases in AChE transcript levels that were 
clearly more evident in denervated muscles in comparison 
to TTX-inactivated counterparts, regardless of the hindlimb 
musculature involved. These decreases in AChE transcript 
levels led to an essentially complete disappearance of the 
selective accumulation of AChE mRNAs  within the post- 
synaptic sarcoplasm, as disclosed by our in situ hybridiza- 
tion experiments. Taken together, these findings indicate that 
although nerve-evoked activity per se appears a key regula- 
tor of both AChE enzyme and mRNA levels in vivo, other 
factors such as the integrity of the synaptic structure and the 
transport of molecules down the axons are capable of main- 
taining AChE enzyme and transcript levels close to normal. 
One implication is that release of nerve-derived trophic fac- 
tors may exert a significant influence on expression of AChE 
in  skeletal muscle fibers.  This proposal has  received par- 
The Journal of Cell Biology, Volume 127,  1994  1066 Figure 7. Loss of AChE mRNA accumulation within the postsynaptic sarcoplasm after complete muscle paralysis. (A) A representative 
bright-field  photomicrograph  of  a longitudinal  cryostat section  of  denervated  EDL muscle fibers stained for the histochemieal  demonstration 
of AChE to localize neuromuscular  junctions (Karnovsky  and Roots, 1964). (B) A dark-field photomicrograph of the same tissue section 
processed for in situ hybridization using a synthetic probe complementary to AChE mRNAs. Short and larger arrows in A and B serve 
as markers for identical tissue locations. Note that contrary to what was observed in control muscle fibers (Fig. 2), there is no codistribution 
of neuromuscular junctions and expression of AChE transcripts in these paralyzed muscle fibers. Bar, 120 #m. 
tial experimental support (Fernandez and Inestrosa,  1976; 
Davey et al.,  1979; Fernandez et al.,  1980; see also for re- 
view Younkin and Younkin, 1988);  yet, the identity of the 
putative trophic factors involved in this regulation still re- 
mains elusive. Since TTX blockade abolishes evoked quan- 
tal acetylcholine release but does not prevent the occurrence 
of spontaneous miniature end-plate potentials (Katz and Mi- 
ledi,  1969;  Pestronk et al.,  1976),  it is possible that ace- 
tylcholine itself, or substances stored and coreleased with 
the neurotransmitter, contribute to this trophic regulation. 
Regulation of  AChE Expression with Respect to AChR 
During the early stages of myogenesis, expression of several 
muscle-specific proteins is greatly enhanced. In particular, 
levels of both AChE and AChR increase sharply during the 
transitional phase from myoblasts to myotubes. As a result 
of exploratory motor axons reaching the surface of the mus- 
cle  fibers,  these two proteins  eventually become concen- 
trated within the synaptic region of  muscle fibers. The appar- 
ent  coregulation  of AChE  and  AChR  expression  is  not 
surprising since the assembly and maintenance of the post- 
synaptic membrane domain of the neuromuscular synapse 
require that expression of all molecular components be tem- 
porally and spatially coordinated. This concept of coregula- 
tion of synaptic proteins has, in fact, been put forward pre- 
viously (Merlie  and  Sanes,  1986;  Klarsfeld,  1987).  One 
prediction based on this model is that expression of  genes en- 
coding synaptic proteins is coregulated. Results obtained in 
several laboratories have revealed a differential accumula- 
tion of mRNAs encoding the various AChR subunits in the 
junctional sarcoplasm (Merlie and Sanes, 1985; Fontaine et 
al., 1988; Fontaine and Changeux, 1989; Goldman and Sta- 
ple, 1989; Brenner et al., 1990) resulting from compartmen- 
talized gene transcription at the level of  junctional myonuclei 
(Klarsfeld et al.,  1991; Sanes et al.,  1992;  Simon et al., 
1992; Duclert et al., 1993). Taken together with our findings 
that AChE transcripts are also found accumulated within the 
postsynaptic sarcoplasm (Jasmin et al.,  1993;  this work), 
these results  suggest that expression of AChE and AChR 
genes is  spatially coregulated along the length of muscle 
fibers. Our results from paralyzed muscles allowed us to ad- 
dress the issue of whether expression of these genes is also 
temporally coregulated. 
It is  well established that upon denervation and TTX- 
induced paralysis of  adult skeletal muscle, transcripts encod- 
ing the subunits of  AChR increase significantly  beyond levels 
normally observod in  innervated muscles  (Merlie  et  al., 
1984;  Fontaine et al.,  1988;  Goldman and Staple,  1989; 
Witzemann et al., 1991). This elevation of  mRNA levels pos- 
sibly reflects transcriptional activation of AChR genes in 
nuclei located in the extrasynaptic sarcoplasm (Fontaine and 
Changeux, 1989; Tsay and Schmidt, 1989). Our observation 
that the levels of AChE mRNA are markedly reduced in 
paralyzed muscles stands in sharp contrast to the findings on 
the expression of AChR.  It strongly indicates that under 
these conditions, expression of these transcripts encoding 
synaptic proteins is independently controlled. Since we did 
not measure transcriptional rates of the AChE gene after pa- 
ralysis, our result may be explained in two ways. First, tran- 
scription of the AChE gene may be severely depressed in 
paralyzed muscles and, therefore, decreased AChE mRNA 
levels may result from a mechanism involving transcriptional 
control. Alternatively, the possibility that transcription of  the 
AChE gene is either unaffected  or even enhanced with a con- 
comitant increase in the rate of mRNA degradation also ex- 
ists.  Although we cannot distinguished between these two 
possibilities at the present time, it is clear that either tran- 
scriptional or posttranscriptional differences exist between 
the regulatory mechanisms involved in the expression of 
AChE and AChR mRNAs in adult skeletal muscle fibers. 
During differentiation and fusion of C2-C12  ceils in cul- 
ture, levels of both AChE and AChR increase along with 
their respective mRNAs (Fuentes and Taylor, 1993). In con- 
trast to the transcriptional activation of the genes encoding 
the AChR subunits, the increase in the abundance of AChE 
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suggesting that expression of these genes is independently 
regulated  during  myogenesis  (Fuentes  and Taylor,  1993). 
However, it still remains to be determined whether expres- 
sion of these genes is also subjected to distinct regulatory 
mechanisms in vivo.  This appears  particularly  essential in 
light of the recent evidence indicating that the mechanisms 
regulating  gene expression in vivo vs in vitro may differ (see 
for example Duclert et al.,  1993).  Thus,  monitoring tran- 
script levels during embryogenesis may provide another op- 
portunity  to test whether expression of the AChE gene is 
coregulated with that of the AChR subunit genes. For exam- 
ple,  if the  downregulation  of one  or more  of the  AChR 
subunit genes (Witzemann et al., 1989) is paralleled by a de- 
cline in AChE transcript levels, it would provide a first indi- 
cation that expression of some of these genes may be coregu- 
lated. A further indication of coregulation would be provided 
by a similar and concomitant pattern of progressive restric- 
tion of these mRNAs as the neuromuscular junction develops 
and is stabilized on the muscle surface.  The implication in 
this case is that during myogenesis and synaptogenesis,  ex- 
pression of these genes is under the control of common sig- 
nalling systems. If this hypothesis is confirmed, then a pic- 
ture  could  emerge  where  expression  of  these  genes  is 
coregulated during development of muscle fibers and assem- 
bly of postsynaptic membrane domains, but is independently 
regulated  in the adult  state  as demonstrated in the present 
work. 
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